Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spyropoulos

Showing results (521-530 of 640) with videos related to

Pageof 64
Sort By:
Proteomics|September 21, 2016
A novel, multiplexed targeted mass spectrometry assay for quantification of complement factor H (CFH) variants and CFH-related proteins 1-5 in human plasmaPingbo Zhang, Min Zhu, Minghui Geng-Spyropoulos, et al.
Molecular and Cellular Biology|March 7, 2007
Thymomegaly, microsplenia, and defective homeostatic proliferation of peripheral lymphocytes in p51-Ets1 isoform-specific null miceTsukasa Higuchi, Frank O Bartel, Masahiro Masuya, et al.
Annals of Gastroenterology|March 23, 2026
Glucagonoma of the pancreas: diagnostic approach and therapeutic algorithm for a rare nosological entityAikaterini Mastoraki, Dimitrios Spyropoulos, Sofia Stamatiadi, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 28, 2021
Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19Luis H Paz Rios, Iva Minga, Esther Kwak, et al.
European Journal of Pharmacology|May 31, 2024
Targeting the interaction of pleiotrophin and VEGFA<sub>165</sub> with protein tyrosine phosphatase receptor zeta 1 inhibits endothelial cell activation and angiogenesisEffrosyni Choleva, Lydia Menounou, Despoina Ntenekou, et al.
Research and Practice in Thrombosis and Haemostasis|March 18, 2021
Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19Alex C Spyropoulos, Stuart L Cohen, Eugenia Gianos, et al.
Journal of Thrombosis and Thrombolysis|March 5, 2021
Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19Dimitrios Giannis, Matthew A Barish, Mark Goldin, et al.
Thrombosis and Haemostasis|January 21, 2025
Influence of Direct Oral Anticoagulant Levels and Thrombin Generation on Postoperative Bleeding [SONAR]: A Nested Case-Control StudyJoseph R Shaw, Na Li, Matthieu Grussé, et al.
Journal of Thrombosis and Haemostasis : JTH|November 10, 2023
Periprocedural management of direct oral anticoagulants in patients with atrial fibrillation and active cancerJoseph R Shaw, Na Li, Jameel Abdulrehman, et al.
Circulation|May 8, 2023
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical TrialGregory Piazza, Alex C Spyropoulos, Judith Hsia, et al.
Pageof 64

Showing results (521-530 of 640) with videos related to

Sort By:
Pageof 64
Proteomics|September 21, 2016
A novel, multiplexed targeted mass spectrometry assay for quantification of complement factor H (CFH) variants and CFH-related proteins 1-5 in human plasmaPingbo Zhang, Min Zhu, Minghui Geng-Spyropoulos, et al.
Molecular and Cellular Biology|March 7, 2007
Thymomegaly, microsplenia, and defective homeostatic proliferation of peripheral lymphocytes in p51-Ets1 isoform-specific null miceTsukasa Higuchi, Frank O Bartel, Masahiro Masuya, et al.
Annals of Gastroenterology|March 23, 2026
Glucagonoma of the pancreas: diagnostic approach and therapeutic algorithm for a rare nosological entityAikaterini Mastoraki, Dimitrios Spyropoulos, Sofia Stamatiadi, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 28, 2021
Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19Luis H Paz Rios, Iva Minga, Esther Kwak, et al.
European Journal of Pharmacology|May 31, 2024
Targeting the interaction of pleiotrophin and VEGFA<sub>165</sub> with protein tyrosine phosphatase receptor zeta 1 inhibits endothelial cell activation and angiogenesisEffrosyni Choleva, Lydia Menounou, Despoina Ntenekou, et al.
Research and Practice in Thrombosis and Haemostasis|March 18, 2021
Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19Alex C Spyropoulos, Stuart L Cohen, Eugenia Gianos, et al.
Journal of Thrombosis and Thrombolysis|March 5, 2021
Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19Dimitrios Giannis, Matthew A Barish, Mark Goldin, et al.
Thrombosis and Haemostasis|January 21, 2025
Influence of Direct Oral Anticoagulant Levels and Thrombin Generation on Postoperative Bleeding [SONAR]: A Nested Case-Control StudyJoseph R Shaw, Na Li, Matthieu Grussé, et al.
Journal of Thrombosis and Haemostasis : JTH|November 10, 2023
Periprocedural management of direct oral anticoagulants in patients with atrial fibrillation and active cancerJoseph R Shaw, Na Li, Jameel Abdulrehman, et al.
Circulation|May 8, 2023
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical TrialGregory Piazza, Alex C Spyropoulos, Judith Hsia, et al.
Pageof 64